Noticias de DRUG_US

Noticias del mercado

Últimas noticias sobre DRUG_US — 22 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: DRUG_US ✕ 22 resultados
27/04/2026 DRUG_US — MSN
Bright Minds announces ATM offering up to $100 million
26/04/2026 DRUG_US — Stock Traders Daily
How Bright Minds Biosciences Inc. (DRUG) Affects Rotational Strategy Timing

Sólo acción del precio: los movimientos de Bright Minds Biosciences Inc. (DRUG) marcan la pauta para los modelos institucionales. Cómo Bright Minds Biosciences Inc. (DRUG) afecta el momento de la estrategia rotacional

26/04/2026 DRUG_US — MSN ES ← EN
Bright Minds anuncia cajero automático que ofrece hasta 100 millones de dólares

Bright Minds announces ATM offering up to $100 million

23/04/2026 DRUG_US — news.google.com
Bright Minds (DRUG) Year-Ahead Outlook | Q4 2025: Earnings Report - Surprise Score
22/04/2026 DRUG_US — sonla.gov.vn ES ← EN
Perspectivas para el año próximo de Bright Minds (DRUG) | Cuarto trimestre de 2025: Informe de resultados: puntuación sorpresa

Bright Minds (DRUG) Year-Ahead Outlook | Q4 2025: Earnings Report - Surprise Score

22/04/2026 DRUG_US — haiphong.gov.vn ES ← EN
Perspectivas para el año próximo de Bright Minds (DRUG) | Cuarto trimestre de 2025: Informe de resultados: puntuación sorpresa
22/04/2026 DRUG_US — MarketBeat
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Consensus Recommendation of "Moderate Buy" from Analysts
18/04/2026 DRUG_US — MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Downgraded to Sell Rating by Wall Street Zen
15/04/2026 DRUG_US — Stock Traders Daily
(DRUG) and the Role of Price-Sensitive Allocations
15/04/2026 DRUG_US — MarketBeat
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Sees Significant Growth in Short Interest
13/04/2026 DRUG_US — MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from Analysts at Jefferies Financial Group
13/04/2026 DRUG_US — Investing.com
Jefferies initiates Bright Minds stock with buy on epilepsy drug
07/04/2026 DRUG_US — MarketScreener
7,787,161 Common Shares of Bright Minds Biosciences Inc. are subject to a Lock-Up Agreement Ending on 8-APR-2026.
07/04/2026 DRUG_US — MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Shares Gap Up - Here's Why
06/04/2026 DRUG_US — MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Trading 7.4% Higher - What's Next?
04/04/2026 DRUG_US — Stock Traders Daily
Responsive Playbooks and the DRUG Inflection
30/03/2026 DRUG_US — Investing.com
BTIG reiterates Bright Minds Biosciences stock rating on seizure treatment potential
30/03/2026 DRUG_US — MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from BTIG Research
28/03/2026 DRUG_US — MarketBeat
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Average Recommendation of "Moderate Buy" from Brokerages
24/03/2026 DRUG_US — Yahoo Finance
What Is the Probability of Success for Bright Minds Biosciences Inc (DRUG)’s Lead Drug Candidate?

Página 1 de 2

keyboard_arrow_up